Suchergebnisse - "Lanoconazole"

PubPharm (9)

1

Pharmacokinetics of lanoconazole in human skin after repeated topical application

enthalten in: The Journal of dermatology | 2022

von Imai, H. | Hashimoto, S. | Ninomiya, R. | +6

2

Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole

enthalten in: Mycoses | 2022

von Nyuykonge, B. | Lim, W. | van Amelsvoort, L. | +6

3

Allergic contact dermatitis due to clobetasol propionate and lanoconazole

enthalten in: Contact dermatitis | 2020

von Kawai, M. | Sowa-Osako, J. | Omura, R. | +2

4

Anti-inflammatory effect of lanoconazole on 12-O-tetradecanoylphorbol-13-acetate- and 2,4,6-trinitrophenyl chloride-induced skin inflammation in mice

enthalten in: Mycoses | 2020

von Nakamura, A. | Uratsuji, H. | Yamada, Y. | +3

5

In-vitro antifungal susceptibility testing of lanoconazole and luliconazole against Aspergillus flavus as an important agent of invasive aspergillosis

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2019

von Omran, S. | Taghizadeh-Armaki, M. | Zarrinfar, H. | +9

6

Potent Activities of Luliconazole, Lanoconazole, and Eight Comparators against Molecularly Characterized Fusarium Species

enthalten in: Antimicrobial agents and chemotherapy | 2018

von Abastabar, M. | Al-Hatmi, A. | Vafaei Moghaddam, M. | +11

7

In Vitro Activities of Luliconazole, Lanoconazole, and Efinaconazole Compared with Those of Five Antifungal Drugs against Melanized Fungi and Relatives

enthalten in: Antimicrobial agents and chemotherapy | 2017

von Shokoohi, G. | Badali, H. | Mirhendi, H. | +6

8

In vitro activity of new azoles luliconazole and lanoconazole compared with ten other antifungal drugs against clinical dermatophyte isolates

enthalten in: Medical mycology | 2016

von Baghi, N. | Shokohi, T. | Badali, H. | +6

9

Anti-inflammatory activity of lanoconazole, a topical antifungal agent

enthalten in: Mycoses | 2015

von Uratsuji, H. | Nakamura, A. | Yamada, Y. | +4

1
[1]